Interactions on record — worth a quick check against your medications. Check your meds →
Dietary supplement

Cogni-Spark Ingredients & Drug Interactions

by Health Concerns

Capsule Category: Non-nutrient/non-botanical
Most serious interaction: Minor
The interaction bottom line Most serious interaction: Minor

Cogni-Spark is a dietary supplement by Health Concerns with 1 active ingredient. Its ingredients are commonly taken for memory and learning support, age-related cognitive decline, alzheimer's disease and dementia (under study).Based on those ingredients, 16 medications have a known interaction with it, the most serious rated minor. The ingredients most likely to interact are Alpha Glycerl-Phosphoryl Choline. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of Cogni-Spark by Health Concerns

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Full disclosure
Ingredient Transparency · database check
Full

Every active ingredient lists its own amount on the label.

Why this rating?
  • The label discloses an exact amount for 1 of its 1 active ingredient.
  • No proprietary blends here — you can verify the dose of every single component.

Cogni-Spark has one active ingredient: alpha-GPC (alpha-glyceryl-phosphoryl choline), a compound your brain uses to make and repair cell membranes and to produce acetylcholine, a neurotransmitter involved in memory and focus. The capsule also contains two inactive ingredients—hypromellose (a capsule material) and rice bran—but no added fillers or binders.

Does it work?

Moderate evidence
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed

This product doesn't appear to be marketed for a specific use, so we graded Alpha-gpc's overall clinical evidence instead.

Moderate

Some clinical evidence supports Alpha-gpc for:

Why this rating?
  • We looked at the product name, claims, and label statements and couldn't find a stated purpose to grade.
  • Since the label doesn't commit to one use, we graded the ingredient's overall clinical evidence instead.
  • On file: Alzheimer disease — rated "Possibly Effective" (Natural Medicines).

The evidence for alpha-GPC is mixed. It's rated possibly effective for Alzheimer disease.

For cognitive function, vascular dementia (reduced blood flow to the brain), stroke recovery, and brain tumor, the evidence is either too limited or unreliable to judge whether it works. If you're considering this for a specific condition, it's worth discussing with your doctor what the current research shows for your situation.

The evidence, ingredient by ingredient Alpha-gpc

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 1 of the 1 matched ingredient.
  • Pregnancy & breastfeeding safety ratings cover 1 of 1.
  • General safety write-ups exist for 1 of 1.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Alpha-GPC is generally well tolerated in studies, but long-term safety hasn't been fully established. A small number of users have reported dizziness, headache, insomnia, excitation, nausea, diarrhea, or heartburn.

Rarely, stroke has been reported with oral use, especially after at least 2 months of continuous use; this rare risk should be weighed against any potential benefit. There isn't enough safety data on file to know whether alpha-GPC is safe during pregnancy or breastfeeding.

If you're pregnant, planning to become pregnant, or nursing, talk with your doctor or pharmacist before starting this supplement.

Side effects, ingredient by ingredient Alpha-gpc

Meds to double-check

Minor interactions only
Known Interaction Concern · database check
Minor only

Only Minor-severity interactions are documented for these ingredients.

Why this rating?
  • 1 of the 1 matched ingredient can interact with medications — Alpha-gpc.
  • The most serious interaction on file is rated Minor.
  • For scale: 16 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

If you use a scopolamine patch (Transderm Scop) for motion sickness, alpha-GPC may weaken its effects on memory and attention—check with your doctor or pharmacist before combining them. Altogether, these interactions span 16 individual medications.

Run your full medication list through the interaction checker on this page before you start.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFully disclosed formula with some supporting evidence behind its ingredients' uses. Only minor medication interactions are documented, and safety information is well characterized.

Cogni-Spark may be worth considering if you're looking into Alzheimer support and want a single-ingredient option, though the evidence is modest. If you take a scopolamine patch or any other medications, check them with your pharmacist first.

The long-term safety profile isn't fully known, so discuss this with your doctor or pharmacist to see if it fits your health picture.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 1 of 1 active ingredient matched to our full ingredient reviews (monographs). Based on the product label dated Jan 22, 2022.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Cogni-Spark, straight from the product label.

Brand Health Concerns
Barcode (UPC) 810034440310
Net contents 30 Capsule(s)
Market status On market
Date entered into DSLD Jan 22, 2022
DSLD ID 259235
Product type Non-nutrient/non-botanical
Supplement form Capsule
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Adult (18 - 50 Years)
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Cogni-Spark by Health Concerns, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container
30
UPC/BARCODE
810034440310
IngredientAmount% DV
Alpha Glycerl-Phosphoryl Choline600 mg--

Other ingredients: Hypromellose, Rice Bran

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
General Statements

Energetic Formulas

Suggested/Recommended/Usage/Directions

Suggested Use: One capsule per day between meals, or as recommended by your health care practitioner.

Precautions

Notice: As with any dietary supplement, do not take without first consulting your health care practitioner, especially if you are pregnant, nursing, or are under medical supervision for any reason.

Notice: As with any dietary supplement, do not take without first consulting your health care practitioner, especially if you are pregnant, nursing, or are under medical supervision for any reason.

Keep out of reach of children.

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Formulation

Made in the U.S.A.

Formula

Apha GPC

FDA Statement of Identity

Dietary Supplement

Brand IP Statement(s)

Health Concerns Combining Modern Research and Ancient Wisdom

See for yourself

Cogni-Spark by Health Concerns label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in Cogni-Spark by Health Concerns

This is the 1 active ingredient this product is made of. Select it to open its full monograph.

Serving size1 Capsule(s) Dosage formCapsule Servings per container30 Amounts shown are per serving.

Alpha Glycerl-Phosphoryl Choline

Interacts with
16 drugs
600 mg per serving

Alpha-GPC is a choline-containing compound used mainly for memory, brain health, and as a choline source. There is some evidence it may help cognition...

Alpha Glycerl-Phosphoryl Choline monograph & interactions

Other (inactive) ingredients: Hypromellose, Rice Bran. These complete the product’s ingredient list but are not active constituents.

Interaction report

Cogni-Spark by Health Concerns Drug Interactions

Want to check YOUR meds against Cogni-Spark?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
16Drugs
16 Minor

Ingredients driving the most interactions

Each ingredient & the kinds of drugs it affects

For each ingredient in Cogni-Spark with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.

Alpha Glycerl-Phosphoryl Choline1 drug type · 16 drugs

Scopolamine (Transderm Scop)

Theoretically, alpha-GPC might decrease the effects of scopolamine.
A small clinical study shows that alpha-GPC can partially counteract the attention and memory impairment effects caused by scopolamine given intramuscularly. Whether alpha-GPC can decrease the beneficial anti-motion sickness effects of the scopolamine patch (Transderm Scop) is unclear.

Likelihood Possible Evidence B
The maker

Brand information

Manufacturer and brand details for Cogni-Spark, from the product label.

Health Concerns

See all Health Concerns products
Name
Health Concerns
City
Springville
State
Utah
Phone Number
1 (800) 233-9355
Web Address
www.healthconcerns.com/pro
Pharmacist Counseling Corner

Cogni-Spark by Health Concerns: Common Questions

Does Cogni-Spark by Health Concerns interact with any medications?
Yes. Based on its ingredients, Cogni-Spark has a known interaction with 16 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Cogni-Spark contains a single active ingredient, and that one ingredient can interact with many different medications on its own. We check it against each medication and show the mechanism responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
What is alpha-GPC and why is it in this product?
Alpha-GPC is a compound that supports brain cell membranes and helps produce acetylcholine, a chemical involved in memory and thinking. It's included in Cogni-Spark to potentially support cognitive and memory function.
Does Cogni-Spark actually help with memory or focus?
The evidence is limited. Alpha-GPC is possibly effective for Alzheimer disease, but for general cognitive function and memory, there isn't enough reliable evidence yet to say whether it works. Your results may depend on your individual situation.
I'm pregnant—is it safe to take this?
There isn't enough safety information available to know whether alpha-GPC is safe during pregnancy. Talk with your doctor or pharmacist before starting it; they can help you weigh whether it's right for you.
What side effects might I notice?
Most people tolerate it well, but a small number have reported headache, dizziness, insomnia, nausea, diarrhea, or heartburn. Rarely, stroke has been reported with longer-term use. If you notice any unusual symptoms, stop and talk with your pharmacist.
I wear a scopolamine patch for motion sickness. Can I take this too?
Alpha-GPC may reduce how the scopolamine patch works on your memory and attention. Check with your doctor or pharmacist before combining them—don't start Cogni-Spark on your own.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Cogni-Spark is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Cogni-Spark label
Sources

Sources & How We Checked

Cogni-Spark's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 4 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Alpha-gpc 4 references
  1. Di Perri R, Coppola G, Ambrosio LA, et al. A multicentre trial to the evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cytosine diphosphocholine in patients with vascular dementia. J Int Med Res 1991;19:330-41.
  2. Barbagallo Sangiorgi G, Barbagallo M, Giordano M, et al. Alpha-glycerophosphocholine in the mental recovery of cerebral ischemic attacks: An Italian multicenter clinical trial. Ann N Y Acad Sci 1994;717:253-69. PubMed
  3. Canal N, Franceschi M, Alberoni M, et al. Effect of L-alpha-glyceryl-phosphorylcholine on amnesia caused by scopolamine. Int J Clin Pharmacol Ther Toxicol 1991;29:103-7.
  4. Lee G, Choi S, Chang J, et al. Association of L-a glycerylphosphorylcholine with subsequent stroke risk after 10 Years. JAMA Netw Open 2021;4(11):e2136008.

See these in context on the Alpha-gpc monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring